Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Riasat Azim, Shulin Wang, Su Zhou & Xing Zhong. (2020) Purity estimation from differentially methylated sites using Illumina Infinium methylation microarray data. Cell Cycle 19:16, pages 2028-2039.
Read now
Read now
Susan R. Sturgeon, Raji Balasubramanian, Catherine Schairer, Hyman B. Muss, Regina G. Ziegler & Kathleen F. Arcaro. (2012) Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics 7:11, pages 1258-1267.
Read now
Read now
Articles from other publishers (34)
Sannidhi Bhootra, Nandana Jill, Geetha Shanmugam, Sudeshna Rakshit & Koustav Sarkar. (2023) DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Medical Oncology 40:2.
Crossref
Crossref
Muthu K. Shanmugam, Chakrabhavi Dhananjaya Mohan, Kanchugarakoppal S. Rangappa, Alan Prem Kumar & Gautam Sethi. 2023. Transcription and Translation in Health and Disease. Transcription and Translation in Health and Disease
325
357
.
Lara Bücker & Ulrich Lehmann. (2022) CDH1 (E-cadherin) Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story. Cancers 14:18, pages 4377.
Crossref
Crossref
Manoj Singh, Vikas Kumar, Nirmala Sehrawat, Mukesh Yadav, Mayank Chaudhary, Sushil K. Upadhyay, Sunil Kumar, Varruchi Sharma, Sandeep Kumar, Neeraj Dilbaghi & Anil K. Sharma. (2022) Current paradigms in epigenetic anticancer therapeutics and future challenges. Seminars in Cancer Biology 83, pages 422-440.
Crossref
Crossref
Bradley M. Downs, Wanjun Ding, Leslie M. Cope, Christopher B. Umbricht, Wenge Li, Huihua He, Xiaokang Ke, Matthias Holdhoff, Chetan Bettegowda, Weiping Tao & Saraswati Sukumar. (2021) Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors. Clinical Epigenetics 13:1.
Crossref
Crossref
Juanjuan Li, Bradley M. Downs, Leslie M. Cope, Mary Jo Fackler, Xiuyun Zhang, Chuan-gui Song, Christopher VandenBussche, Kejing Zhang, Yong Han, Yufei Liu, Suzana Tulac, Neesha Venkatesan, Timothy de Guzman, Chuang Chen, Edwin W. Lai, Jingping Yuan & Saraswati Sukumar. (2021) Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer. npj Breast Cancer 7:1.
Crossref
Crossref
Zahra Mohammadi, Mehdi Azad, Farshad Foroughi, Sahar Khojastehpour, Nematollah Gheibi, Fatemeh Samiee-Rad, Amirhosein Maali & MohammadHossein Ahmadi. (2021) Evaluation of expression level and methylation profile of CXX1 gene in breast cancer tissue blocks. Journal of Cancer Research and Therapeutics 17:6, pages 1328.
Crossref
Crossref
Igor Stastny, Pavol Zubor, Karol Kajo, Peter Kubatka, Olga Golubnitschaja & Zuzana Dankova. (2020) Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer. Clinical Breast Cancer 20:6, pages e711-e722.
Crossref
Crossref
Yuling Bin, Yong Ding, Weisheng Xiao & Aijun Liao. (2020) RASSF1A: A promising target for the diagnosis and treatment of cancer. Clinica Chimica Acta 504, pages 98-108.
Crossref
Crossref
Bradley M. Downs, Claudia Mercado-Rodriguez, Ashley Cimino-Mathews, Chuang Chen, Jing-Ping Yuan, Eunice Van Den Berg, Leslie M. Cope, Fernando Schmitt, Gary M. Tse, Syed Z. Ali, Danielle Meir-Levi, Rupali Sood, Juanjuan Li, Andrea L. Richardson, Marina B. Mosunjac, Monica Rizzo, Suzana Tulac, Kriszten J. Kocmond, Timothy de Guzman, Edwin W. Lai, Brian Rhees, Michael Bates, Antonio C. Wolff, Edward Gabrielson, Susan C. Harvey, Christopher B. Umbricht, Kala Visvanathan, Mary Jo Fackler & Saraswati Sukumar. (2019) DNA Methylation Markers for Breast Cancer Detection in the Developing World. Clinical Cancer Research 25:21, pages 6357-6367.
Crossref
Crossref
I. M. Alhudiri, C. C. Nolan, I. O. Ellis, A. Elzagheid, E. A. Rakha, Andrew R. Green & C. J. Chapman. (2019) Expression of Lamin A/C in early-stage breast cancer and its prognostic value. Breast Cancer Research and Treatment 174:3, pages 661-668.
Crossref
Crossref
Roisin M. Connolly, Mary Jo Fackler, Zhe Zhang, Xian C. Zhou, Matthew P. Goetz, Judy C. Boughey, Bridget Walsh, John T. Carpenter, Anna Maria Storniolo, Stanley P. Watkins, Edward W. Gabrielson, Vered Stearns & Saraswati Sukumar. (2017) Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. Breast Cancer Research and Treatment 167:1, pages 107-116.
Crossref
Crossref
Eva Jezkova, Pavol Zubor, Karol Kajo, Marian Grendar, Karol Dokus, Marian Adamkov, Zora Lasabova, Lukas Plank & Jan Danko. (2017) Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients. Oncology Letters 14:1, pages 758-766.
Crossref
Crossref
Jing Li, Yanbo Chen, Hongyuan Yu, Jingshen Tian, Fengshun Yuan, Jialong Fan, Yupeng Liu, Lin Zhu, Fan Wang, Yashuang Zhao & Da Pang. (2017) DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk. Scientific Reports 7:1.
Crossref
Crossref
Eva Jezkova, Karol Kajo, Pavol Zubor, Marian Grendar, Bibiana Malicherova, Andrea Mendelova, Karol Dokus, Zora Lasabova, Lukas Plank & Jan Danko. (2016) Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients. Tumor Biology 37:12, pages 15707-15718.
Crossref
Crossref
Jolien S. de Groot, Cathy B. Moelans, Sjoerd G. Elias, Mary Jo Fackler, Robert van Domselaar, Karijn P.M. Suijkerbuijk, Arjen J. Witkamp, Saraswati Sukumar, Paul J. van Diest & Elsken van der Wall. (2016) DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection. Oncotarget 7:17, pages 24778-24791.
Crossref
Crossref
Willemijne A. M. E. Schrijver, Laura S. Jiwa, Paul J. van Diest & Cathy B. Moelans. (2015) Promoter hypermethylation profiling of distant breast cancer metastases. Breast Cancer Research and Treatment 151:1, pages 41-55.
Crossref
Crossref
Ruchika Kaul-Ghanekar, Snehal Suryavanshi & Prerna Raina. 2015. Noninvasive Molecular Markers in Gynecologic Cancers. Noninvasive Molecular Markers in Gynecologic Cancers
61
142
.
Christine B. Ambrosone, Chi-Chen Hong & Pamela J. Goodwin. 2015. Improving Outcomes for Breast Cancer Survivors. Improving Outcomes for Breast Cancer Survivors
143
153
.
Menha Swellam, Mohamed D.E. Abdelmaksoud, Magda Sayed Mahmoud, Amal Ramadan, Walid Abdel-Moneem & Mona M. Hefny. (2015)
Aberrant methylation of
APC
and
RAR
β
2
genes in breast cancer patients
. IUBMB Life 67:1, pages 61-68.
Crossref
Crossref
Timothy M. Barrow & Karin B. Michels. (2014) Epigenetic epidemiology of cancer. Biochemical and Biophysical Research Communications 455:1-2, pages 70-83.
Crossref
Crossref
Jolien S. de Groot, Xiaojuan Pan, Jan Meeldijk, Elsken van der Wall, Paul J. van Diest & Cathy B. Moelans. (2014) Validation of DNA promoter hypermethylation biomarkers in breast cancer — a short report. Cellular Oncology 37:4, pages 297-303.
Crossref
Crossref
Q.W. CHEN, X.Y. ZHU, Y.Y. LI & Z.Q. MENG. (2014) Epigenetic regulation and cancer (Review). Oncology Reports 31:2, pages 523-532.
Crossref
Crossref
Debmalya Barh, Angelo Carpi, Mukesh Verma & Mehmet GunduzRuchika Kaul-Ghanekar, Snehal Suryavanshi & Prerna Raina. 2014. Cancer Biomarkers. Cancer Biomarkers
545
614
.
Catherine A. Moroski-Erkul, Burak Yilmaz, Esra Gunduz & Mehmet Gunduz. 2014. Omics Approaches in Breast Cancer. Omics Approaches in Breast Cancer
17
40
.
Yi-Teng Huang, Fei-Fei Li, Chen Ke, Zhou Li, Zong-Tai Li, Xiao-Fang Zou, Xiao-Xuan Zheng, Yu-Ping Chen & Hao Zhang. (2013) PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy. Journal of Translational Medicine 11:1.
Crossref
Crossref
Sabrina A. Bardowell, Joel Parker, Cheng Fan, Jamie Crandell, Charles M. Perou & Theresa Swift-Scanlan. (2013) Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns. Breast Cancer Research and Treatment 142:2, pages 365-380.
Crossref
Crossref
Mi Jung Kwon, Ji Hyun Kwon, Eun Sook Nam, Hyung Sik Shin, Dong Jin Lee, Jin Hwan Kim, Young Soo Rho, Chang Ohk Sung, Won Jae Lee & Seong Jin Cho. (2013) TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma. Human Pathology 44:9, pages 1722-1729.
Crossref
Crossref
Jia-Min B Pang, Alexander Dobrovic & Stephen B Fox. (2013) DNA methylation in ductal carcinoma in situof the breast. Breast Cancer Research 15:3.
Crossref
Crossref
Daria Witt, Peter Burfeind, Sandra von Hardenberg, Lennart Opitz, Gabriela Salinas-Riester, Felix Bremmer, Stefan Schweyer, Paul Thelen, Jürgen Neesen & Silke Kaulfuß. (2013) Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2. Carcinogenesis 34:5, pages 1115-1124.
Crossref
Crossref
Jacob Ulirsch, Cheng Fan, George Knafl, Ming Jing Wu, Brett Coleman, Charles M. Perou & Theresa Swift-Scanlan. (2012) Vimentin DNA methylation predicts survival in breast cancer. Breast Cancer Research and Treatment 137:2, pages 383-396.
Crossref
Crossref
B. Alex Merrick. 2012. Toxicology and Epigenetics. Toxicology and Epigenetics
387
407
.
J. G. Bijron, P. van der Groep, E. B. van Dorst, L. M. S. Seeber, D. M. D. S. Sie-Go, R. H. M. Verheijen & P. J. van Diest. (2011) Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers. Endocrine Related Cancer 19:1, pages 69-81.
Crossref
Crossref
Yoon Hee Cho, Jing Shen, Marilie D. Gammon, Yu-Jing Zhang, Qiao Wang, Karina Gonzalez, Xinran Xu, Patrick T. Bradshaw, Susan L. Teitelbaum, Gail Garbowski, Hanina Hibshoosh, Alfred I. Neugut, Jia Chen & Regina M. Santella. (2011) Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Research and Treatment 131:1, pages 197-205.
Crossref
Crossref